KIM
NVS icon

Kestra Investment Management’s Novartis NVS Stock Holding History

Kestra Investment Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Buy
2,037
+347
+21% +$52K 0.01% 406
2026
Q1 		$258K Buy
1,690
+227
+16% +$34.8K ﹤0.01% 392
2025
Q4 		$202K Buy
+1,463
New +$192K ﹤0.01% 424
2025
Q3 		– Sell
-8
Closed -$892 – 822
2025
Q2 		$892 Hold
8
– – ﹤0.01% 939
2025
Q1 		$892 Sell
8
-477
-98% -$50.8K ﹤0.01% 825
2024
Q4 		$47.2K Buy
+485
New +$51.7K ﹤0.01% 552

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kestra Investment Management's NVS Position: Q2 2026 in Review

Kestra Investment Management increased its Novartis (NVS) stake by 21% in Q2 2026, buying an estimated $52K and bringing the position to 2,037 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #406.

Kestra Investment Management first reported a position in NVS in Q4 2024 and has held it in 6 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Kestra Investment Management held 2,037 shares of Novartis worth $319K as of Q2 2026.
  • Kestra Investment Management bought 347 Novartis shares in Q2 2026, an estimated $52K.
  • Novartis made up 0.01% of Kestra Investment Management's portfolio in Q2 2026, its #406 holding.
  • Kestra Investment Management first reported a position in Novartis in Q4 2024 and has held it in 6 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.